Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Total Non-Current Liabilities (2026)

Updated

Lantern Pharma (LTRN) recorded Total Non-Current Liabilities of $4.32 million in Q2 2026.

Analysis

Lantern Pharma (LTRN) Total Non-Current Liabilities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 105.50 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 106.45 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 33.91 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 35.10 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 97.04 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn - 4.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.32 Mn
API Access

Lantern Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LTRN&period=max&api_key=YOUR_API_KEY